Phase II Study of Autologous Myeloma-Derived Immunoglobulin Idiotype Conjugated to Keyhole Limpet Hemocyanin Plus Sargramostim (GM-CSF) in Patients With Multiple Myeloma Undergoing Second Autologous Peripheral Blood Stem Cell Transplantation
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Keyhole limpet haemocyanin; Melphalan; Multiple myeloma vaccine; Sargramostim
- Indications Multiple myeloma
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- 10 Jul 2013 New trial record
- 20 Jun 2013 Biomarkers information updated